Transcend Therapeutics
2 known investors
Transcend Therapeutics develops rapid-acting pharmaceutical treatments for neuropsychiatric diseases, including PTSD and depression, targeting patients unresponsive to current psychiatric medications. The company is a clinical-stage biotech firm focused on neuroscience-based drug development.
BiotechDigital HealthMedical DevicesMental Health